Market capitalization: > 1 Billion
Dividend Yield: > 3 < 20
Return on investment: > 10 < 100
Operating Margin: > 10 < 100
10 Year Revenue Growth: > 8 < 200
10 Year EPS Growth: > 10 < 100
Here are my favorite stocks:
Vale (ADR) (NYSE:VALE) has a market capitalization of $93.33 billion. The company employs 70,785 people, generates revenues of $58,990.00 million and has a net income of $21,517.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $34,234.00 million. Because of these figures, the EBITDA margin is 58.03 percent (operating margin 51.05 percent and the net profit margin finally 36.48 percent).
Financial Analysis: The total debt representing 19.04 percent of the company’s assets and the total debt in relation to the equity amounts to 31.53 percent. Due to the financial situation, a return on equity of 30.99 percent was realized. Twelve trailing months earnings per share reached a value of $3.77. Last fiscal year, the company paid $1.73 in form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 4.85, P/S ratio 1.69 and P/B ratio 1.21. Dividend Yield: 6.26 percent. The beta ratio is 1.55.
| Long-Term Stock History Chart Of Vale (ADR) (Click to enlarge) |
| Long-Term Dividends History of Vale (ADR) (VALE) (Click to enlarge) |
| Long-Term Dividend Yield History of Vale (ADR) (NYSE: VALE) (Click to enlarge) |
Novartis AG (NYSE:NVS) has a market capitalization of $126.03 billion. The company employs 123,686 people, generates revenues of $59,375.00 million and has a net income of $9,245.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $15,751.00 million. Because of these figures, the EBITDA margin is 26.53 percent (operating margin 18.52 percent and the net profit margin finally 15.57 percent).
Financial Analysis: The total debt representing 17.22 percent of the company’s assets and the total debt in relation to the equity amounts to 30.72 percent. Due to the financial situation, a return on equity of 14.12 percent was realized. Twelve trailing months earnings per share reached a value of $3.55. Last fiscal year, the company paid $2.25 in form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.66, P/S ratio 2.40 and P/B ratio 1.90. Dividend Yield: 4.77 percent. The beta ratio is 0.52.
| Long-Term Stock History Chart Of Novartis AG (ADR) (Click to enlarge) |
| Long-Term Dividends History of Novartis AG (ADR) (NVS) (Click to enlarge) |
| Long-Term Dividend Yield History of Novartis AG (ADR) (NYSE: NVS) (Click to enlarge) |
CNOOC Limited (NYSE:CEO) has a market capitalization of $80.10 billion. The company employs 5,377 people, generates revenues of $37,899.77 million and has a net income of $11,050.90 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $18,571.11 million. Because of these figures, the EBITDA margin is 49.00 percent (operating margin 37.60 percent and the net profit margin finally 29.16 percent).
Financial Analysis: The total debt representing 9.89 percent of the company’s assets and the total debt in relation to the equity amounts to 14.45 percent. Due to the financial situation, a return on equity of 29.36 percent was realized. Twelve trailing months earnings per share reached a value of $24.64. Last fiscal year, the company paid $5.80 in form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 7.28, P/S ratio 2.15 and P/B ratio 1.94. Dividend Yield: 3.80 percent. The beta ratio is 1.43.
| Long-Term Stock History Chart Of CNOOC Limited (ADR) (Click to enlarge) |
| Long-Term Dividends History of CNOOC Limited (ADR) (CEO) (Click to enlarge) |
| Long-Term Dividend Yield History of CNOOC Limited (ADR) (NYSE: CEO) (Click to enlarge) |
Abbott Laboratories (NYSE:ABT) has a market capitalization of $97.22 billion. The company employs 91,000 people, generates revenues of $38,851.26 million and has a net income of $4,728.45 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,795.84 million. Because of these figures, the EBITDA margin is 22.64 percent (operating margin 14.81 percent and the net profit margin finally 12.17 percent).
Financial Analysis: The total debt representing 25.57 percent of the company’s assets and the total debt in relation to the equity amounts to 63.07 percent. Due to the financial situation, a return on equity of 20.07 percent was realized. Twelve trailing months earnings per share reached a value of $3.23. Last fiscal year, the company paid $1.92 in form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 19.12, P/S ratio 2.50 and P/B ratio 3.97. Dividend Yield: 3.30 percent. The beta ratio is 0.31.
| Long-Term Stock History Chart Of Abbott Laboratories (Click to enlarge) |
| Long-Term Dividends History of Abbott Laboratories (ABT) (Click to enlarge) |
| Long-Term Dividend Yield History of Abbott Laboratories (NYSE: ABT) (Click to enlarge) |
![]() |
| Best Dividend Paying Stocks June 2012 (Click to enlarge)) |

Tremendous issues here. I'm very glad to peer your post. Thank you a lot and I'm looking ahead
ReplyDeleteto touch you. Will you please drop me a e-mail?
Here is my webpage ; Credit Repair Reviews